27 results on '"Mu, Zhaomei"'
Search Results
2. Longitudinal Dynamics of Circulating Tumor Cells and Circulating Tumor DNA for Treatment Monitoring in Metastatic Breast Cancer
3. Junctional Adhesion Molecules in Cancer: A Paradigm for the Diverse Functions of Cell–Cell Interactions in Tumor Progression
4. CCR5 Governs DNA Damage Repair and Breast Cancer Stem Cell Expansion
5. Cell-Free DNA and Circulating Tumor Cells: Comprehensive Liquid Biopsy Analysis in Advanced Breast Cancer
6. Detection of activating estrogen receptor gene (ESR1) mutations in single circulating tumor cells
7. Detection of Activating Estrogen Receptor Gene (ESR1) Mutations in Single Circulating Tumor Cells
8. Detection and Characterization of Circulating Tumor Associated Cells in Metastatic Breast Cancer.
9. A Phase I/II Study of the Investigational Drug Alisertib in Combination With Abiraterone and Prednisone for Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Abiraterone
10. Detection and Characterization of Circulating Tumor Associated Cells in Metastatic Breast Cancer
11. Edelfosine Promotes Apoptosis in Androgen-Deprived Prostate Tumors by Increasing ATF3 and Inhibiting Androgen Receptor Activity
12. Arterial Blood, Rather Than Venous Blood, is a Better Source for Circulating Melanoma Cells
13. Abstract 2788: Comprehensive high-depth target sequencing in circulating tumor DNAs of patients with inflammatory and non-inflammation breast cancers
14. Abstract P4-01-11: Circulating tumor cells (CTCs) detect HER2+ status and phenotypic heterogeneity in metastatic breast cancer (MBC)
15. Abstract P6-14-06: CCR5 antagonists suppresses the migration and invasion of human inflammatory breast cancer cells
16. AZD8931, an equipotent, reversible inhibitor of signaling by epidermal growth factor receptor (EGFR), HER2, and HER3: preclinical activity in HER2 non-amplified inflammatory breast cancer models.
17. Abstract 4988: Clues for targeted therapies in inflammatory breast cancer (IBC)
18. AZD8931, an equipotent, reversible inhibitor of signaling by epidermal growth factor receptor (EGFR), HER2, and HER3: preclinical activity in HER2 non-amplified inflammatory breast cancer models
19. A Chromosome-centric Human Proteome Project (C-HPP) to Characterize the Sets of Proteins Encoded in Chromosome 17
20. Presence of anaplastic lymphoma kinase in inflammatory breast cancer
21. EZH2 knockdown suppresses the growth and invasion of human inflammatory breast cancer cells.
22. EZH2 knockdown suppresses the growth and invasion of human inflammatory breast cancer cells
23. Abstract 5342: FC-IBC-02: A new in vitro-in vivo model of inflammatory breast cancer (IBC)
24. Abstract LB-387: EZH2 knockdown suppresses the growth of human inflammatory breast cancer cells both in vitro and in vivo in xenograft models
25. Cleavage of the Cytoplasmic Domain of the Integrin β3 Subunit during Endothelial Cell Apoptosis
26. Cleavage of the Cytoplasmic Domain of the Integrin β3Subunit during Endothelial Cell Apoptosis*
27. CTC enumeration and characterization: moving toward personalized medicine.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.